Moderna DCGI approval
<p>
<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/u_sjSfIMxCE" title="YouTube video player" width="560"></iframe></p>
<p>
In a major development, pharma major Cipla has been cleared from DCGI to import Moderna&#39;s Covid vaccine for restricted emergency use in India. It will be the fourth vaccine to be administered in India after Covishield, Covaxin and Sputnik V. Moderna&#39;s Covid vaccine is an mRNA-based vaccine with an efficacy rate of 94.1 percent, according to a WHO estimate. Keep watching to know more!</p>
Prime Minister Narendra Modi met with Nigerian President Bola Ahmed Tinubu at the Presidential Villa…
At the ongoing COP29 climate conference in Azerbaijan, India expressed dissatisfaction on the insistence of…
Rampant youth unemployment in China has left millions of young people struggling, staying at home,…
The eighth annual Nepal-India border security coordination meeting commenced in Kathmandu on Saturday, with security…
A large group of female students from Degree College Chilas staged a protest and blocked…
Union Minister of State for Health and Family Welfare, Anupriya Singh Patel on Saturday addressed…